An observational study assessing the management of gastrointestinal and urogenital bleeding events in patients with atrial fibrillation treated with dabigatran etexilate (GI/GU bleeding management in AF patients using dab)First published 21/11/2013 Last updated 30/03/2024 EU PAS number: EUPAS5214StudyFinalised
United BioSource Corporation (UBC)Switzerland First published: 25/04/2013Last updated 06/03/2024 InstitutionNon-Pharmaceutical companyENCePP partner